がん治療用生物製剤とは、がん細胞の増殖や転移に関与する特定の分子や経路を標的とするように設計された薬剤の一群を指します。生物製剤は通常、タンパク質、抗体、ワクチンなどの生物に由来し、がん細胞上の特定の標的と相互作用するように設計されています。これらの薬剤は、様々な種類のがんの治療に用いられることが多く、単独で使用されることもあれば、化学療法、放射線療法、手術などの他の治療法と併用されることもあります。がん治療用生物製剤は、生物学的療法、生物療法、または標的療法と呼ばれることもあります。世界のがん治療用生物製剤市場の主な推進要因は、がんの発生率の増加と、標的を絞った個別化医療の需要の増加です。さらに、技術の進歩と有利な規制環境は、2023年から2030年の予測期間にわたって市場に有利な成長機会を生み出しています。
がんの発生率の増加は、がん治療用生物製剤市場の主な推進要因の1つです。 GLOBOCAN 2020の統計によると、2020年の世界の新規がん症例数は1,930万人でした。 この数は、2040 年までに 3,020 万人に増加すると予想されています。このがん症例の大幅な増加は、さまざまな種類のがんの治療に有望である小分子薬を含む、効果的ながん治療が緊急に必要であることを浮き彫りにしています。ただし、がん治療用生物製剤のコストが高いため、2023年から2030年の予測期間を通じて市場の成長が抑制されます。
世界のがん治療用生物製剤市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカのがん治療用生物製剤市場は、大手製薬会社の存在、高額な医療費、がん罹患率の増加により、最大となると予想されています。アメリカは先進がん治療の導入率が高いため、市場を独占すると予想されています。アジア太平洋地域のがん治療用生物製剤市場は、がん罹患率の増加、医療インフラの改善、研究開発への投資の増加などの要因により、大幅な成長が見込まれています。中国と日本が市場の成長に大きく貢献すると予想されます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cancer Biologics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cancer Biologics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Cancer Biologics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cancer Biologics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Biologics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Biologics Market Dynamics
3.1. Cancer Biologics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Incidence of cancer
3.1.1.2. Increasing demand for targeted and personalized medicine
3.1.2. Market Challenges
3.1.2.1. High Cost of Cancer Biologics
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Favorable regulatory environment
Chapter 4. Global Cancer Biologics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Biologics Market, by Product
5.1. Market Snapshot
5.2. Global Cancer Biologics Market by Product, Performance - Potential Analysis
5.3. Global Cancer Biologics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Cancer Biologics Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Cytokine-Based Immunotherapy
5.4.3. Cancer Vaccines
5.4.4. CAR-T Cell Therapy
5.4.5. Immune Checkpoint Inhibitors
Chapter 6. Global Cancer Biologics Market, by Application
6.1. Market Snapshot
6.2. Global Cancer Biologics Market by Application, Performance - Potential Analysis
6.3. Global Cancer Biologics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cancer Biologics Market, Sub Segment Analysis
6.4.1. Non-small Cell Lung Cancer
6.4.2. Prostate Cancer
6.4.3. Breast Cancer
6.4.4. Acute Myeloid Leukemia
6.4.5. Lymphoma
6.4.6. Others
Chapter 7. Global Cancer Biologics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Cancer Biologics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Cancer Biologics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Cancer Biologics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others
Chapter 8. Global Cancer Biologics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cancer Biologics Market, Regional Market Snapshot
8.4. North America Cancer Biologics Market
8.4.1. U.S. Cancer Biologics Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cancer Biologics Market
8.5. Europe Cancer Biologics Market Snapshot
8.5.1. U.K. Cancer Biologics Market
8.5.2. Germany Cancer Biologics Market
8.5.3. France Cancer Biologics Market
8.5.4. Spain Cancer Biologics Market
8.5.5. Italy Cancer Biologics Market
8.5.6. Rest of Europe Cancer Biologics Market
8.6. Asia-Pacific Cancer Biologics Market Snapshot
8.6.1. China Cancer Biologics Market
8.6.2. India Cancer Biologics Market
8.6.3. Japan Cancer Biologics Market
8.6.4. Australia Cancer Biologics Market
8.6.5. South Korea Cancer Biologics Market
8.6.6. Rest of Asia Pacific Cancer Biologics Market
8.7. Latin America Cancer Biologics Market Snapshot
8.7.1. Brazil Cancer Biologics Market
8.7.2. Mexico Cancer Biologics Market
8.8. Middle East & Africa Cancer Biologics Market
8.8.1. Saudi Arabia Cancer Biologics Market
8.8.2. South Africa Cancer Biologics Market
8.8.3. Rest of Middle East & Africa Cancer Biologics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Roche Holding AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. Merck & Co., Inc.
9.3.4. Bristol-Myers Squibb Company
9.3.5. Amgen Inc.
9.3.6. Johnson & Johnson
9.3.7. Pfizer Inc.
9.3.8. AstraZeneca plc
9.3.9. Eli Lilly and Company
9.3.10. AbbVie Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Cancer Biologics Market, report scope
TABLE 2. Global Cancer Biologics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Cancer Biologics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Cancer Biologics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Cancer Biologics Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Cancer Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Cancer Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Cancer Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Cancer Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Cancer Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Cancer Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Cancer Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Cancer Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Cancer Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Cancer Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Cancer Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Cancer Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Cancer Biologics Market
TABLE 71. List of primary sources, used in the study of global Cancer Biologics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Cancer Biologics Market, research methodology
FIG 2. Global Cancer Biologics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Biologics Market, key trends 2022
FIG 5. Global Cancer Biologics Market, growth prospects 2023-2030
FIG 6. Global Cancer Biologics Market, porters 5 force model
FIG 7. Global Cancer Biologics Market, pest analysis
FIG 8. Global Cancer Biologics Market, value chain analysis
FIG 9. Global Cancer Biologics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Cancer Biologics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Cancer Biologics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Cancer Biologics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Cancer Biologics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Cancer Biologics Market, regional snapshot 2020 & 2030
FIG 15. North America Cancer Biologics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Cancer Biologics Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Cancer Biologics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Cancer Biologics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Cancer Biologics Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
